Tag

Kailera

5 stories

Kailera Raises $625M in Record Biotech IPO on Nasdaq

Kailera Therapeutics raised $625 million Friday in a record-setting biotech IPO on the Nasdaq.

Raised $625M at $16 a Share, Kailera Tops Moderna's 2018 IPO Record

Kailera Therapeutics priced just under 40 million shares at $16 apiece Friday, pulling in $625 million on its Nasdaq debut under KLRA.

Deals 3 days ago

Kailera Prices $625m IPO, One of the Largest Biotech Offerings Since Moderna 2018

Kailera Therapeutics priced its IPO at $625m, or $16 a share, on April 16 — at the top of its S-1 range and one of the largest biotech public offerings…

Deals 3 days ago

Priced at $16, Kailera Raises $625M in Largest Biotech IPO Since 2018

Kailera Therapeutics priced its IPO at $16 a share Friday, raising $625 million, the largest biotech public offering in recent memory, topping Moderna's…

Deals Apr 13, 2026

Kailera Files $528.5M Nasdaq IPO to Fund Four GLP-1 Obesity Drugs

Kailera filed for a $528.5 million Nasdaq IPO, pricing 33.33 million shares at $14 to $16 each.